You are in the accessibility menu

Please use this identifier to cite or link to this item: http://acervodigital.unesp.br/handle/11449/40202
Full metadata record
DC FieldValueLanguage
dc.contributor.authorGomes, Karina Santos-
dc.contributor.authorde Carvalho-Netto, Eduardo Ferreira-
dc.contributor.authorDa Silva Monte, Katia Cristina-
dc.contributor.authorAcco, Bruno-
dc.contributor.authorde Campos Nogueira, Paulo Jose-
dc.contributor.authorNunes-de-Souza, Ricardo Luiz-
dc.date.accessioned2014-05-20T15:30:55Z-
dc.date.accessioned2016-10-25T18:06:37Z-
dc.date.available2014-05-20T15:30:55Z-
dc.date.available2016-10-25T18:06:37Z-
dc.date.issued2009-03-30-
dc.identifierhttp://dx.doi.org/10.1016/j.brainresbull.2008.11.003-
dc.identifier.citationBrain Research Bulletin. Oxford: Pergamon-Elsevier B.V. Ltd, v. 78, n. 6, p. 323-327, 2009.-
dc.identifier.issn0361-9230-
dc.identifier.urihttp://hdl.handle.net/11449/40202-
dc.identifier.urihttp://acervodigital.unesp.br/handle/11449/40202-
dc.description.abstractThe elevated T-maze (ETM) is an animal model of anxiety-like behavior that assesses two different defensive behavioral tasks in the same animal-acquisition of inhibitory avoidance and latency to escape from an open and elevated arm. In rats, cute and chronic treatments with anxiolytic-like drugs impair avoidance acquisition while only chronic administration of panicolytic-like drugs impairs open arm withdrawal. To date, only the acute effects of anxiolytic/anxiogenic or panicolytic/panicogenic drugs have been tested in the mouse ETM and the results have partially corroborated those found in the rat ETM. This study investigated the effects of acute (a single intraperitoneal injection 30 min before testing) and chronic (daily i.p. injections for 15 consecutive days) treatment with imipramine or fluoxetine, non-selective and selective serotonin reuptake inhibitors, respectively, on inhibitory avoidance and escape tasks in the mouse ETM. Neither acute nor chronic treatment with imipramine (0, 1, 5 or 10 mg/kg, i.p.) significantly changed the behavioral profile of mice in the two ETM tasks. Interestingly, while acute fluoxetine (0, 5, 10, 20 or 40 mg/kg, i.p.) facilitated inhibitory avoidance and impaired escape latency, chronic treatment (0, 5, 20 or 40 mg/kg, i.p.) with this selective serotonin reuptake inhibitor (SSRI) produced an opposite effect, i.e., it impaired inhibitory avoidance acquisition and facilitated open arm withdrawal. Importantly, acute or chronic treatment with imipramine (except at the highest dose that increased locomotion when given acutely) or fluoxetine failed to alter general locomotor activity in mice as assessed in an ETM in which all arms were enclosed by lateral walls (eETM). These results suggest that inhibitory avoidance acquisition is a useful task for the evaluation of acute and chronic effects of SSRI treatment on anxiety in mice. However, as open arm latency was actually increased and reduced by acute and chronic fluoxetine, respectively, this does not seem to be a useful measure of escape from a proximal threat in this species. (C) 2008 Elsevier B.V. All rights reserved.en
dc.description.sponsorshipFundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)-
dc.description.sponsorshipConselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)-
dc.description.sponsorshipPrograma de Apoio ao Desenvolvimento Científico da Faculdade de Ciências Farmacêuticas da UNESP (PADC)-
dc.description.sponsorshipCoordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES)-
dc.format.extent323-327-
dc.language.isoeng-
dc.publisherPergamon-Elsevier B.V. Ltd-
dc.sourceWeb of Science-
dc.subjectAntidepressantsen
dc.subjectImipramineen
dc.subjectFluoxetineen
dc.subjectAcute and chronic treatmenten
dc.subjectElevated T-mazeen
dc.subjectInhibitory avoidanceen
dc.subjectEscapeen
dc.subjectMiceen
dc.titleContrasting effects of acute and chronic treatment with imipramine and fluoxetine on inhibitory avoidance and escape responses in mice exposed to the elevated T-mazeen
dc.typeoutro-
dc.contributor.institutionUniversidade Estadual Paulista (UNESP)-
dc.contributor.institutionUniversidade de São Paulo (USP)-
dc.description.affiliationFCFAr Campus UNESP, Lab Neuropsicofarmacol, BR-14801902 Araraquara, SP, Brazil-
dc.description.affiliationFFCLRP Campus USP, Programa Posgrad Psicobiol, BR-14040901 Ribeirao Preto, SP, Brazil-
dc.description.affiliationICB Campus USP, Lab Neuroanat Func, BR-05508900 São Paulo, Brazil-
dc.description.affiliationUnespFCFAr Campus UNESP, Lab Neuropsicofarmacol, BR-14801902 Araraquara, SP, Brazil-
dc.description.sponsorshipIdFAPESP: 02/03705-0-
dc.description.sponsorshipIdFAPESP: 03/05261-5-
dc.description.sponsorshipIdCNPq: 309407/2006-0-
dc.identifier.doi10.1016/j.brainresbull.2008.11.003-
dc.identifier.wosWOS:000263700600009-
dc.rights.accessRightsAcesso restrito-
dc.relation.ispartofBrain Research Bulletin-
Appears in Collections:Artigos, TCCs, Teses e Dissertações da Unesp

There are no files associated with this item.
 

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.